Metraipolis › archive › dc_84d1bb768563

C16-siRNAs in Focus: Development of ALN-APP, a Promising RNAi-Based Therapeutic for Alzheimer's Disease — Europe PMC PMID:41599628

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41599628
DOI
10.3390/ph19010026
License (as archived)
solo-consultazione
Archived
2026-11-07T11:42:58.528Z
SHA-256 of the archived text
dac7e99ab6f4264f1aae037794176426f436020a296b330a755e9f8e154df622
Stable URL of this page
https://metraipolis.com/documento/dc_84d1bb768563

How to cite

C16-siRNAs in Focus: Development of ALN-APP, a Promising RNAi-Based Therapeutic for Alzheimer's Disease — Europe PMC PMID:41599628 — Europe PMC (en), https://europepmc.org/article/MED/41599628 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_84d1bb768563 (Metraipolis archive dc_84d1bb768563, sha256 dac7e99ab6f4264f1aae037794176426f436020a296b330a755e9f8e154df622)
BibTeX
@misc{dc84d1bb768563,
  title = {C16-siRNAs in Focus: Development of ALN-APP, a Promising RNAi-Based Therapeutic for Alzheimer's Disease — Europe PMC PMID:41599628},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41599628},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_84d1bb768563; sha256 dac7e99ab6f4264f1aae037794176426f436020a296b330a755e9f8e154df622},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41599628. Agents can read the archived copy with the MCP tool read_document.